151 related articles for article (PubMed ID: 9794391)
1. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells.
Barber DL; Corless CN; Xia K; Roberts TM; D'Andrea AD
Blood; 1997 Jan; 89(1):55-64. PubMed ID: 8978277
[TBL] [Abstract][Full Text] [Related]
4. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.
Friedmann MC; Migone TS; Russell SM; Leonard WJ
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2077-82. PubMed ID: 8700888
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.
Lennartsson J; Blume-Jensen P; Hermanson M; Pontén E; Carlberg M; Rönnstrand L
Oncogene; 1999 Sep; 18(40):5546-53. PubMed ID: 10523831
[TBL] [Abstract][Full Text] [Related]
6. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of the interleukin (IL)-2 receptor beta chain into an IL-7-dependent pre-B cell line permits IL-2-driven proliferation: tyrosine phosphorylation of Shc is induced by IL-2 but not IL-7.
Dorsch M; Hock H; Diamantstein T
Eur J Immunol; 1994 Sep; 24(9):2049-54. PubMed ID: 8088325
[TBL] [Abstract][Full Text] [Related]
8. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
10. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
[TBL] [Abstract][Full Text] [Related]
11. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC
J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines.
Durstin M; Inhorn RC; Griffin JD
J Immunol; 1996 Jul; 157(2):534-40. PubMed ID: 8752899
[TBL] [Abstract][Full Text] [Related]
13. Requirement for Shc in TCR-mediated activation of a T cell hybridoma.
Pratt JC; van den Brink MR; Igras VE; Walk SF; Ravichandran KS; Burakoff SJ
J Immunol; 1999 Sep; 163(5):2586-91. PubMed ID: 10452997
[TBL] [Abstract][Full Text] [Related]
14. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
15. Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor.
de Koning JP; Soede-Bobok AA; Schelen AM; Smith L; van Leeuwen D; Santini V; Burgering BM; Bos JL; Lowenberg B; Touw IP
Blood; 1998 Mar; 91(6):1924-33. PubMed ID: 9490675
[TBL] [Abstract][Full Text] [Related]
16. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation.
Ravichandran KS; Burakoff SJ
J Biol Chem; 1994 Jan; 269(3):1599-602. PubMed ID: 8294403
[TBL] [Abstract][Full Text] [Related]
17. The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2.
Guthridge MA; Barry EF; Felquer FA; McClure BJ; Stomski FC; Ramshaw H; Lopez AF
Blood; 2004 Feb; 103(3):820-7. PubMed ID: 12920017
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation.
Zhu X; Suen KL; Barbacid M; Bolen JB; Fargnoli J
J Biol Chem; 1994 Feb; 269(8):5518-22. PubMed ID: 8119884
[TBL] [Abstract][Full Text] [Related]
20. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
